Answers are grounded in this paper and cite their sources.
This case report describes the implementation of a heparin desensitisation strategy for a patient with confirmed galactose-alpha-1,3-galactose (alpha-gal) allergy, prior to cardiac surgery. We describe the pre-, intra- and postoperative management. We believe this report can enhance the limited data currently in existence on alternative strategies for heparin utilisation in cardiopulmonary bypass in a previously intolerant patient population.
No takes yet. Share an insight, caveat, or question.
McRae et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: